SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-13-413490
Filing Date
2013-10-28
Accepted
2013-10-28 16:28:10
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 d607848d424b5.htm 424B5 959072
2 GRAPHIC g607848g02h45.jpg GRAPHIC 136455
3 GRAPHIC g607848g02m08.jpg GRAPHIC 20766
4 GRAPHIC g607848g02m08_k.jpg GRAPHIC 12903
5 GRAPHIC g607848g11g35.jpg GRAPHIC 62116
6 GRAPHIC g607848g18n99.jpg GRAPHIC 66991
7 GRAPHIC g607848g18t96.jpg GRAPHIC 41640
8 GRAPHIC g607848g56o02.jpg GRAPHIC 132662
9 GRAPHIC g607848g75s36.jpg GRAPHIC 34936
  Complete submission text file 0001193125-13-413490.txt   1661948
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-189538 | Film No.: 131173404
SIC: 8731 Services-Commercial Physical & Biological Research